Article
Genomic Alterations and Possible Druggable Mutations in Carcinoma of Unknown Primary (CUP)
2021-05-27
Abstract excerpt
Carcinoma of Unknown Primary (CUP) is a heterogeneous and metastatic disease where the primary site of origin is undetectable. Currently, chemotherapy is the only state-of-art treatment option for CUP patients. Using molecular profiling of the tumour, particularly mutation detection, offers a new treatment for CUP in a personalized fashion using targeted agents. We analyzed the mutation and copy number alterations...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1e154618-d20b-5cf0-9f9f-cab850d8f821
- DOI
- 10.21203/rs.3.rs-554581/v1
